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The presence of blood pressure (BP) quantitative trait loci (QTL) on rat chromosome 10 has been clearly demonstrated by linkage analysis and
substitution mapping. Using congenic strains containing the LEW rat chromosomal segments on the Dahl salt-sensitive (S) rat background, further
iterations of congenic substrains were constructed and characterized to fine-map a chromosome 10 region (QTL1) linked to blood pressure.
Comparison of seven congenic substrains refined QTL1 to a 1.17 Mb segment flanked by D10Mco88 and D10Mco89, which are located at
71,513,116 and 72,684,774 bp, respectively. The newly defined QTL1, containing 18 genes, is captured in its entirety within a single congenic
substrain. A thorough transcript analysis revealed that 3 of these 18 genes, Ccl5, Ddx52, and RGD1559577, had nonsynonymous allelic variations
between the S rat and the LEW rat. None of the detected transcripts within the newly defined QTL1 are implicated directly in BP control in
humans or model organisms. Therefore, the present work defines a novel blood pressure QTL with three potential quantitative trait nucleotides.
© 2006 Elsevier Inc. All rights reserved.Keywords: Quantitative trait locus; Hypertension; Dahl rats; Ddx52; Ccl5Human essential hypertension is a classic example of a
complex trait with documented genetic influence. However, the
underlying disease-causative genetic components remain
unknown. Genetic studies using selectively bred hypertensive
rat models provide some advantages over genetic studies of
hypertension in humans, one of which is the ability to conduct
substitution mapping using consomic/congenic strains [1–3].
Such efforts have not only accumulated evidence for the
presence of multiple quantitative trait loci (QTLs) that regulate
blood pressure (BP), but also mapped several of these QTLs on
the rat genome with high resolution. One such previous study
from our laboratory resulted in the identification of the QTL on
rat chromosome (RNO) 7 as 11β-hydroxylase [4,5]. Causative⁎ Corresponding author. Fax: +1 419 383 6168.
E-mail address: bina.joe@utoledo.edu (B. Joe).
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doi:10.1016/j.ygeno.2006.12.005genetic variants within all other BP QTL regions remain
unidentified.
The present report is on the genetic analysis of RNO10.
Multiple studies, involving 10 different rat strains, have
provided evidence for the existence of multiple loci on this
chromosome linked to BP [6–26]. The Dahl salt-sensitive (S)
versus LEWand S versus Milan normotensive strain (MNS) are
the two strain comparisons studied in our laboratory using
substitution mapping. A BP QTL was previously located within
12 cM (D10Mco58 to D10Rat24) using S.LEW congenic
strains, whereas a BP QTL was located within 2.6 cM
(D10Rat27 to D10Rat24) using S.MNS congenic strains [15].
The objective of the present work was to dissect further the 12-
cM QTL1 region identified using the S and LEW comparison.
For this purpose, new iterations of congenic substrains were
developed and studied, which resulted in an 18-fold improved
localization of BP QTL1 from the previous localization. The
344 Y. Saad et al. / Genomics 89 (2007) 343–353refined region is 1.17 Mb containing 18 annotated genes, none
of which are known to play a role in rodent or human BP
control. Therefore, BP QTL1 represents a potentially novel
underlying genetic factor controlling BP.
The final step from fine-mapping to identifying the underlying
genetic determinant by the substitution mapping approach is one
of themost difficult steps ofQTLmapping for two reasons: (1) the
larger the introgressed segment, the greater the number of
positional candidates to evaluate, each of which may or may not
influence blood pressure, and (2) the smaller the congenic
interval, the greater the difficulty in finding animals with infor-
mative recombinations to construct congenic substrains with
shorter introgressed segments. At this stage, multiple comple-
mentary techniques become necessary to link the observed QTL
effect to any locus within the fine-mapped QTL interval. Because
nonsynonymous polymorphisms may result in altered protein
function, genes with such variants are primary suspects for
correlatedQTL effects. Therefore, in addition to fine-mapping the
BPQTL1, we sought to prioritize gene identification of BPQTL1
based on the presence or absence of nonsynonymous variants
within the expressed transcripts of positional candidate genes.
Data obtained, which indicate that multiple genes within QTL1
possess potential coding sequence quantitative trait nucleotides
(QTNs), will be presented.
Results
RNO10 BP QTL1 region of S.LEWx12
S.LEWx12 was the congenic strain previously used to
define QTL1 on the genetic linkage map of RNO10. By
defining the ends of the introgressed region of S.LEWx12, a
more current and accurate localization of QTL1 on the
physical map of RNO10 was determined. The QTL1 region
contained within the S.LEWx12 congenic strain was located
between D10Got79 (63,481,418 bp) and D10Rat269
(79,137,099 bp) of RNO10 (www.ensembl.org) (Fig. 1). This
15,655,681-bp interval of RNO10 encompasses 221 genes
(www.ncbi.nlm.nih.gov/genome/guide/rat).
Congenic substrains of S.LEWx12
Fig. 1 shows the tiling array of congenic substrains that were
developed to span the 15.66-Mb BP QTL1 region trapped within
the S.LEWx12 congenic strain. The lack of an effect on BP (Fig. 1,
Table 1) between theS rat strain and the congenic substrains shown
with black bars (S.LEWx12x6, S.LEWx12x2x1, S.LEWx12x3,
and S.LEWx12x4) points to a 1.17 Mb region flanked by
markers D10Mco88 and D10Mco89 as the newly refined
location of QTL1. In support of this observation, congenicFig. 1. Congenic substrains derived from S.LEWx12 and their BP effects. Bars illustra
ends of each introgressed segment represent the region of recombination. Green ba
lowering effect, whereas the black bars represent the LEW introgressed segment in con
used to genotype the congenic substrains. The base-pair chromosomal location for the
effect observed for each congenic substrain compared to that of the S rat BP (effect=c
current (orange bar) S.LEW RNO10 BP QTL localizations as they relate to the cytosubstrains S.LEWx12x1 and S.LEWx12x2 (green bars), both
spanning this region, demonstrated a significant (p<0.0001)
decrease in BP compared to the S rat (35 and 22 mmHg,
respectively) (Fig. 1, Table 1). These data were further
corroborated using the congenic substrain S.LEWx12x2x3,
which contained the fine-mapped QTL1 within a shorter
introgressed segment. The BP of S.LEWx12x2x3 was sig-
nificantly lower by 17 mmHg (p<0.0001) compared to the S rat
(Fig. 1, Table 1). The significant heart weight effects observed
with S.LEWx12, S.LEWx12x1, S.LEWx12x2, and S.
LEWx12x2x3 correlated with the BP effects that were observed
for these congenic substrains.
Tail-cuff versus telemetry comparison
Fig. 2A shows that tail-cuff BP measurements correlated
highly with the telemetry BP measurements. The group averages
of the S rat BP were not significantly different between the two BP
measurement approaches (tail-cuff versus telemetry, Fig. 2B).
Similarly, no significant difference was observed between the
group averages of S.LEWx12x2. However, the S versus S.
LEWx12x2 comparison was significantly different (p<0.0001)
for both tail-cuff and telemetrymeasurements. The 8-day telemetry
BP measurements for S and S.LEWx12x2 are shown in Fig. 2C.
Throughout the 8-day period, the S.LEWx12x2 congenic strain,
which contains the QTL1 region, showed a significant (p<0.0001)
systolic BP-lowering effect compared to the S rat.
Genetic composition and comparative mapping of the QTL1
region
The fine-mapped QTL1 region flanked by D10Mco88 and
D10Mco89, which are located at 71,513,116 and 72,684,774 bp,
respectively, corresponds to 1,171,658 bp (Fig. 3). This region of
RNO10 represents 0.042% of the rat genome with 18 gene
annotations. Eleven of these are known genes and 7 are predicted
genes. Conserved synteny of QTL1 on mouse chromosome 11
and human chromosome 17 (www.ncbi.nlm.nih.gov) is pre-
sented in Fig. 3. Comparative mapping suggested that 13 of the
18 gene annotations within QTL1 are orthologous to genes on
mouse chromosome 11, whereas only 11 rat gene annotations are
orthologous to genes on human chromosome 17. Based on
sequence similarity, there is no information currently available
for human orthologs of the remaining 7 rat genes that exist
anywhere else on the human genome.
Features of the S.LEW BP QTL1 gene transcripts
The authenticity of all 18 gene annotations (including both
known genes and predicted genes) within QTL1 was assessedte the LEW segment introgressed onto the background of S. The open bars at the
rs represent the LEW introgressed segment in congenic substrains with a BP-
genic substrains without a BP-lowering effect. Dashed lines point to the markers
start of each marker is given in parenthesis. The lower portion illustrates the BP
ongenic substrain BP−S rat BP). Also illustrated is the previous (yellow bar) and
genetic map and the megabase scale of RNO10.
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Table 1
Effects of rat chromosome 10 congenic strains on blood pressure, body weight, heart weight, and relative heart weight
Congenic strain Blood pressure (mmHg) Body weight (g)
S Congenic Effect a t test S Congenic Effect a t test
S.LEWx12 242 [3.70] 217 [4.28] –25 (5.66) <0.0001 303 [2.86] 303 [1.14] 0 (3.08) 0.910
S.LEWx12x1 218 [3.10] 183 [2.07] –35 (4.27) <0.0001 311 [2.11] 299 [5.81] –12 (5.81) 0.110
S.LEWx12x2 215 [3.72] 184 [3.05] –31 (4.76) <0.0001 297 [3.75] 299 [3.42] +2 (5.07) 0.619
S.LEWx12x3 191 [1.58] 186 [3.21] –5 (3.71) 0.444 320 [1.52] 315 [2.77] –5 (3.59) 0.314
S.LEWx12x4 b, c 190 [1.61] 192 [2.45] +2 (2.81) 0.525 314 [2.00] 306 [2.61] –8 (3.23) 0.012
S.LEWx12x6 c 189 [2.92] 192 [3.89] +3 (4.45) 0.842 307 [3.23] 291 [3.33] –16 (4.49) 0.002
S.LEWx12x2x1 196 [2.53] 191 [4.07] –5 (4.79) 0.315 318 [2.25] 317 [2.48] –1 (3.35) 0.697
S.LEWx12x2x3 b 206 [2.23] 189 [2.28] –17 (3.20) <0.0001 303 [1.92] 305 [1.96] +2 (2.75) 0.449
Heart weight (g) Relative heart weight
S.LEWx12 1.31 [0.015] 1.22 [0.009] –0.09 (0.018) <0.0001 4.26 [0.067] 4.02 [0.035] –0.24 (0.075) 0.003
S.LEWx12x1 1.23 [0.018] 1.10 [0.019] –0.13 (0.028) <0.0001 3.96 [0.053] 3.68 [0.032] –0.27 (0.058) <0.0001
S.LEWx12x2 1.26 [0.038] 1.16 [0.015] –0.10 (0.039) 0.023 4.26 [0.163] 3.89 [0.039] –0.36 (0.156) 0.025
S.LEWx12x3 1.25 [0.010] 1.21 [0.010] –0.04 (0.015) 0.059 3.90 [0.024] 3.86 [0.033] –0.04 (0.054) 0.713
S.LEWx12x4 b, c 1.21 [0.007] 1.21 [0.011] 0 (0.004) 0.720 3.88 [0.029] 3.98 [0.059] +0.10 (0.061) 0.145
S.LEWx12x6 c 1.18 [0.013] 1.18 [0.011] 0 (0.016) 0.751 3.85 [0.048] 4.09 [0.068] +0.24 (0.083) 0.222
S.LEWx12x2x1 1.26 [0.047] 1.26 [0.016] 0 (0.022) 0.728 3.95 [0.048] 3.99 [0.048] +0.04 (0.068) 0.564
S.LEWx12x2x3 b 1.25 [0.013] 1.21 [0.007] –0.04 (0.016) 0.014 4.15 [0.050] 3.99 [0.024] –0.16 (0.059) 0.006
The number of rats in each group ranged from 20 to 23 except for the following comparisons: S.LEWx12x4 vs S (32 vs 44 rats) and S.LEWx12x2x3 vs S (30 vs 30
rats). Only male rats were used. Standard error of the mean is shown in square brackets. Standard error of the mean difference is shown in parentheses.
a Effect is the congenic value minus the S value. Negative values indicate a decrease in the congenic effect compared to the S rat, whereas positive values indicate
an increase in the congenic effect compared to the S rat.
b The values given here are the averages of two separate experiments for S.LEWx12x4 and three separate experiments for S.LEWx12x2x3 were done.
c Heart weight values given were corrected for body weight using the regression between heart weight and body weight.
346 Y. Saad et al. / Genomics 89 (2007) 343–353by reverse transcription of S and LEW total RNA followed by
sequencing of the resultant cDNA. A total of 15 of the 18
transcripts were confirmed as expressed transcripts. Product
sizes of 12 of the 15 cDNA preparations in both S and LEW rats
were as expected based on the annotations by the NCBI
database (www.ncbi.nlm.nih.gov). The 12 genes are Mmp28,
Ccl5, LOC497971, Ccl6, Ccl3, Ccl4, Expi, LOC360228,
RGD1566204, Ddx52, Tada2l, and Acaca (Table 2). cDNA
products for the other three genes (Tcf2, Ap1gbp1, and Dusp14)
were the same in both S and LEW rats, but the product sizes
were not consistent with the predictions by the NCBI database
(Table 2).
To ensure that the list of candidate transcripts was
comprehensive, we also compared our results with the
annotations at the Ensembl rat database (www.ensembl.org),
which has annotated the rat genome independent of the
annotations by NCBI [27]. Our results are in agreement with
the Ensembl and NCBI transcript predictions for most of the
genes, but with some exceptions. First, the NCBI prediction for
the Tcf2 transcript was shorter by 3 nucleotides compared to the
transcript prediction by Ensembl. Tcf2 transcripts from both S
and LEW rats were in agreement with the Ensembl prediction
indicating that the translated product would result in an
additional amino acid, Q403, of Tcf2. Second, NCBI prediction
of the Dusp14 transcript is longer than what is predicted by the
Ensembl database. Our results are in agreement with the
Ensembl database. We were not able to reverse transcribe the
first 396 bp of the Dusp14 NCBI annotated sequence.
Therefore, for completeness that sequence was confirmed by
sequencing the genomic DNA of S and LEW. Third, theAp1gbp1 transcript sequence of both S and LEW mostly
resembled the sequence annotated by Ensembl, which is
different from that of NCBI. Last, the Mmp28 transcript size
and sequence were the same as given by NCBI, but shorter by
21 nucleotides representing 7 amino acids at the C-terminal of
the protein predicted by Ensembl.
Note that of the 18 genes annotated within the QTL interval,
7 genes are predicted, with no previous evidence for rat
transcripts. Amplification of transcripts within the QTL region
allowed us to test the authenticity of some of the predicted
genes. Regardless of the product sizes, we observed cDNA
products from 4 (Mmp28, LOC497971, RGD1566204, and
Dusp14) of these 7 predictions, thus providing evidence that
they are indeed true rat transcripts. There are three gene
predictions (RGD1559577, Taf15, and RGD1559875) for
which we did not detect any transcribed products either in the
S or in the LEW rat. This does not necessarily imply that these
predicted transcripts do not exist in the rat. Based on the
genomic sequence analysis of these predicted transcripts we are
able to conclude that there are no allelic variations between
these predicted transcripts of S and LEW.
Genetic variants within positional transcripts of the QTL1
region
Table 2 shows the three nonsynonymous variants that were
identified between the S and the LEW genes located within the
QTL1 region. Of the 18 genes found within the QTL1 region,
only 3 potentially informative nonsynonymous S and LEW
allelic variants were detected. The three variants belonged to the
Fig. 2. Corroboration of tail-cuff measurements by telemetry. (A) Correlation between the blood measurement values obtained by tail-cuff and telemetry on the same
group of S and S.LEWx12x2 rats. (B) Comparison of the mean values of S rats and S.LEWx12x2 rats measured by tail-cuff and telemetry. (C) Daily average systolic
blood pressure (SBP) telemetry measurements of S versus S.LEWx12x2.
347Y. Saad et al. / Genomics 89 (2007) 343–353chemokine (C-C motif) ligand 5 (Ccl5), ATP-dependent RNA
helicase (Ddx52), and predicted RGD1559577 genes, respec-
tively. Testing of other inbred strains (i.e., SHRSP, WKY, MHS,
and MNS) revealed that all four strains carried the LEW variant
for all three nonsynonymous polymorphic nucleotides identi-
fied in the S.LEW comparison (data not shown). Furthermore,
the only other BP QTL that overlaps our QTL region and is
corroborated using a congenic strain is the SHRSP.WKY
comparison (Fig. 4). Since SHRSP and WKY were not
polymorphic at any of the three candidate variants that were
found between S and LEW, these sites are not QTNs for the BP
QTL located using WKY.SHRSP.
Discussion
This study describes the fine-mapping of a BP QTL to a
relatively small 1.17-Mb region on RNO10 with only 18 genes.
Improved resolution of this magnitude allowed for a compre-hensive scanning of all the genes for nucleotide variants or
QTNs. This was accomplished systematically, first by collecting
all known bioinformatic data for the existence of each of the
known/predicted transcripts in S and LEW rats, sequencing all
exons, and finally confirming each of the variants using
genomic DNA from S and LEW rats. Based on the results
described here, further analysis of three genes could be
prioritized. Thus at this stage of mapping, the possibility for
multiple QTNs that contribute to the overall QTL effect of
S.LEW QTL1 cannot be ruled out.
Confidence in the current improved localization of QTL1 is
supported by two lines of evidence. First, support is provided by
the collective BP data for all the congenic substrains that were
tested. The congenic substrains that we tested were carefully
chosen and constructed in such a way as to provide redundancy.
The iterations of congenic substrains used in this study allowed
for a two- to fivefold redundancy for any given chromosomal
segment being tested for its BP effect. Second, the BP-lowering
Fig. 3. Comparative mapping of the newly defined S.LEWRNO10 BP QTL1. The LEW introgressed segment of the minimal congenic substrain S.LEWx12x2x3 is represented by the green bar. The open segments at the
ends of the green bar represent the regions of recombination. The region spanning the 1.17 Mb from 71,513,116 to 72,684,774 bp is the newly refined S.LEW QTL1 region. Also illustrated are the 18 NCBI (www.ncbi.
nlm.nih.gov) annotated genes for the S.LEW QTL1 region. NCBI annotations of the mouse chromosome 11 and human chromosome 17 syntenic regions are also illustrated. The base-pair location from the start to end
for each gene is given in parenthesis.
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Table 2
Nonsynonymous allelic variants of S and LEW genes located within the chromosome 10 BP QTL1 region
Gene
ID
Gene
symbol
Gene
description
Transcript size (ATG to stop) RNO10
location
Exon S rat
variant
LEW rat
variant
Observed S
allele
Observed LEW
allele
497969 RGD1559577 Similar to Riken cDNA 1700020L24 (predicted) No product a No product a 71,525,070 bp b 4 TTC (F326) TAC (Y326)
303384 Mmp28 Matrix metalloproteinase 28 (predicted) 1578 bp^ 1578 bp^ No variants — — —
287571 Taf15 TBP-associated factor 15 (predicted) No product a No product a No variants — — —
497970 RGD1559875 Similar to novel protein (predicted) No product a No product a No variants — — —
81780 Ccl5 Chemokine (C-C motif) ligand 5 279 bp 279 bp 71,610,248 bp c 1 ATT (I14) GTT (V14)
497971 LOC497971 Similar to Ccl9 (predicted) 354 bp 354 bp No variants — — —
287910 Ccl6 Chemokine (C-C motif) ligand 6 348 bp 348 bp No variants — — —
25542 Ccl3 Chemokine (C-C motif) ligand 3 279 bp 279 bp No variants — — —
116637 Ccl4 Chemokine (C-C motif) ligand 4 279 bp 279 bp No variants — — —
171059 Expi Extracellular peptidase inhibitor 183 bp 183 bp No variants — — —
360228 LOC360228 WDNM1 homolog 192 bp 192 bp No variants — — —
497972 RGD1566204 Similar to 2700008B19Rik protein (predicted) 3759 bp 3759 bp No variants — — —
25640 Tcf2 Transcription factor 2 1677 bp†^ 1677 bp†^ No variants — — —
85432 Ddx52 ATP-dependent, RNA helicase 1797 bp 1797 bp 72,223,895 bp d 2 AAA (K73) ACA (T73)
84479 Ap1gbp1 AP1 γ-subunit binding protein 1 3417 bp†^ 3417 bp†^ No variants — — —
360580 Dusp14 Dual specificity phosphate 14 (predicted) 597 bp^ 597 bp^ No variants — — —
360581 Tada2l Transcriptional adapter 2-like 1332 bp† 1332 bp† No variants — — —
60581 Acaca Acetyl-coenzyme A carboxylase α 7038 bp 7038 bp No variants — — —
Total kidney RNAwas used to obtain all the transcripts except for RGD1566204 and Ap1gbp1.Amixed pool of total RNA obtained from S and LEW rat liver, spleen,
heart, pancreas, lung, and thyroid was used to obtain the RGD1566204 and Ap1gbp1 transcripts. The S vs LEW variant nucleotide is shown in bold. The amino acid
and its position within the protein are in parentheses. Some genes, designated by †, showed more than one type of transcript variant. All transcript sizes were of
expected size, according to NCBI, with some exceptions designated by ^. The Mmp28 transcript size and sequence were the same as given by NCBI, but Ensembl’s
annotation was shorter by 7 amino acids at the C-terminal. The Tcf2 transcript size and sequence were the same as that given by NCBI, except that the S and LEW
transcripts had an additional amino acid (Q403) that the NCBI does not annotate. That amino acid is annotated by Ensembl and is also found in the mouse sequence of
this gene’s protein product. The Dusp14 transcript obtained was similar to that annotated by Ensembl and overlapped with the last segment of the sequence annotated
by NCBI. The first 396 bp of the Dusp14NCBI annotated sequence was confirmed by sequencing the genomic DNA of S and LEW. The Ap1gbp1 transcript sequence
and size differed from both NCBI’s and Ensembl’s. However, the sequence mostly resembled the sequence annotated by Ensembl. Some of the observed transcript
variants had sizes and sequences that looked more like a composite between the NCBI and the Ensembl deposited sequences for this gene. For all the genes, the gene-
specific primers used in amplifying the gene transcripts, genomic DNA amplification, and amplicon sequencing were designed based on the NCBI’s deposited
sequences. All nonsynonymous variants observed in the amplified transcripts were confirmed by sequencing the genomic DNA. All S and LEW sequences
characterized for these genes were deposited with GenBank under accession numbers ranging from EF121971 to EF122008.
a Total kidney RNA and the mixed pool of RNAwere tried for those few genes that did not give a transcript product. Sequence information for those genes that did
not give a transcript product was obtained by sequencing the genomic DNA.
b Chromosomal location is position 12,524,275 of Accession No. NW_047336 viewed on plus strand.
c Chromosomal location is position 12,609,453 of Accession No. NW_047336 viewed on plus strand.
d Chromosomal location is position 13,223,100 of Accession No. NW_047336 viewed on plus strand.
349Y. Saad et al. / Genomics 89 (2007) 343–353effect was observed in the S.LEWx12x2x3 congenic substrain,
which spans the deduced QTL region of interest with minimal
flanking introgressed region. Moreover, relative heart weight
has served as a good surrogate indicator of blood pressure.
Unlike other reports of heart weight or left ventricular mass
QTLs that are under independent control of blood pressure [28–
33], the heart weight effects of our study are likely due to the
fact that the hypertrophy of the heart develops as a result of an
increase in blood pressure and peripheral resistance. In any case,
the S.LEWx12x2x3 congenic substrain serves as the primary
tool for further substitution mapping of the BP QTL.
There are many rat strain comparisons used to locate and
identify BP QTLs on RNO10. Among these, a relatively
greater degree of fine-mapping has been achieved using the S
versus LEW comparison. Independent studies, including the
current study, have provided evidence for at least five different
BP QTLs on RNO10 (Fig. 4). The novel BP QTL that we have
localized in the S and LEW comparison within 71,513,116 and
72,684,774 bp on RNO10 is designated as S.LEW QTL1. ThisQTL is flanked by two other mean arterial pressure QTL
regions (C10QTL1 and C10QTL4) that do not overlap our
current localization [18]. Based on our studies, we cannot
replicate the data of Charron et al., who have reported the
localization of two BP QTLs, labeled as C10QTL4 within
70.57 and 71.39 Mb of RNO10 and C10QTL1 within 74.86
and 76.03 Mb of RNO10. The exact reasons for this
discrepancy are not known. However, the lengths of the
introgressed segments within congenic strains used for
substitution mapping in the study by Charron et al. [18] are
different from those used in our study. Complex interallelic
interactions or closely linked modifiers of the QTL effect may
be present in one congenic strain and not the other, accounting
for these differences. Alternatively, differences in experimental
approaches could be contributing to the observed discrepan-
cies. More importantly, however, we point out that, coupled
with the fact that a minimal congenic strain encompassing our
BP QTL region from 71,513,116 to 72,684,774 bp was not
tested in the study by Charron et al. [18], support for the
Fig. 4. A summary of BP QTL mapping on RNO10. Illustrated to the left of the cytogenetic map are the flank and peak lod markers previously obtained for the F2
(S×LEW) population [12]. To the right of the cytogenetic map represented in yellow is our previous S.LEW QTL1 localization as it relates to our current (orange) S.
LEW QTL1 localization. A collection of other RNO10 substitution mapping (green), linkage analyses with defined flanking markers (red), and linkage analyses with
poorly defined flanking markers (blue) is given for comparison. Numbers underneath the mapping locations are citation numbers. Rat strain nomenclature: S, Dahl
salt-sensitive rat; LEW, Lewis; MNS, Milan normotensive strain; SHRSP, spontaneously hypertensive stroke-prone; WKY, Wistar Kyoto; SHR, spontaneously
hypertensive rat; BN, Brown Norway; MHS, Milan hypertensive strain; BB, biobreeding; ISIAH, inherited stress-induced arterial hypertension; WAG, Wistar Albino
Glaxo; GH, genetically hypertensive.
350 Y. Saad et al. / Genomics 89 (2007) 343–353localization of our BP QTL is also provided by three of the
congenic strains (S.LC10, S.L4, and S.L10) used in the study
by Charron et al. [18].
Our newly defined S.LEW QTL1 region contains 1,171,658
bp. Theoretically, each one of these nucleotides, unless proven
otherwise, is a candidate QTN for S.LEW QTL1. Therefore, an
exhaustive search for positional QTNs would include sequen-
cing the S and LEW genomes across the 1.17 Mb QTL interval.
This approach has the advantage of generating a catalog of
sequence variants within genes and also within inter- and
intragenic regions. However, we prioritized the identification of
nonsynonymous variants because these variants can potentially
directly affect protein structure and function. Therefore, thelogical first step for us was to rule out, as comprehensively as
possible, any coding sequence variations within candidate
transcripts that result in altered primary amino acid sequences.
Of the 34,005 bp that represent predicted and known
transcripts within the QTL region, only 3 exist as nonsynon-
ymous variants between S and LEW. A single nonsynonymous
variant was identified within each of three equally prioritized
potential BP candidate genes located within QTL1. One of these
variants is within the Ddx52 gene, which is a member of the
DEAD box (Asp-Glu-Ala-Asp/His) protein family of RNA
helicases. Mutations within this gene may alter cellular
functions related to transcription and translation (mRNA
splicing/stability, ribosome assembly, and translation initiation)
351Y. Saad et al. / Genomics 89 (2007) 343–353[34]. A high degree of homology between the rat, the mouse,
and the human DDX52 proteins (95% rat versus mouse and
88% rat versus human) implies an important evolutionarily
conserved function for this gene. As a result of the transcript
variant detected, the predicted Ddx52 S rat protein had lysine
(K) at amino acid position 73. Interestingly, the K at position 73
observed in the S rat is conserved across species, in both mouse
and human, the relevance of which to the context of the BP QTL
effect is not immediately discernable.
There is a cluster of proinflammatory chemokines present as
positional candidateswithinQTL1.Of these, only one variant was
identified within the proinflammatory chemokine Ccl5 gene. Rat
Ccl5 protein has 94 and 79% homology to that of the mouse and
human, respectively. However, amino acid position 14, where the
valine (V) was substituted with an isoleucine (I) in S rats, was not
conserved among species. The V14–I14 variant is within the
signal peptide sequence of the Ccl5 protein, which is excised
during protein transport. Even single amino acid changes can
influence the functionality of the signal peptide of a protein [35].
Whether the detected variant influences any functional aspects of
Ccl5 in S compared to the LEW remains to be tested.
The importance of the nonsynonymous variant found within
RGD1559577 is difficult to hypothesize because of the anonymity
of the gene. Therefore, further studies of this positional candidate
remain a challenge. Furthermore, it is not knownwhether the three
genes with nonsynonymous variants operate independent of each
other or with other yet undetected genetic factors to exert the
observed QTL effect. It is not uncommon for QTL effects to be
exerted by a complex concerted action ofmany underlying genetic
factors [36].
Clearly, further substitution mapping is required to assign
causation to any/all of these candidate QTNs. Further substitu-
tion mapping is possible, but takes a considerable amount of
time and resources, provided enough hot spots for recombina-
tion are available within the 1.17-Mb S.LEW QTL1 region. At
this stage of mapping, a candidate gene approach based on
previously inferred function or differential gene expression
analysis is commonly used to expedite QTL identification [37–
44]. Each approach has its advantages and disadvantages. The
candidate gene approach is not a comprehensive approach. For
example, it is feasible that more than one closely positioned
genetic factor may be quantitative trait loci for the same
phenotype [45]. Custom QTL-chips are used to comprehen-
sively enlist differentially expressed positional candidate genes
[42], but lack the ability to pin-point candidate QTNs. The
comprehensive transcript sequence analysis described in our
study certainly has limitations due to the fact that candidate
QTNs outside of the coding regions are not detected. Our results
do, however, demonstrate that multiple closely positioned genes
contain potential QTNs for S.LEW QTL1.
Although large regions of rat chromosome 10 are homo-
logous to human chromosome 17, wherein BP QTLs are
reported, homology mapping indicates that the 1.17-Mb S.LEW
QTL1 is not within regions of interest for regulating human BP.
Therefore, it is conceivable that genetic factors underlying
S.LEW QTL1 constitute novel, yet undiscovered, mechanisms
of BP control in humans.Materials and methods
Strains
The inbred Dahl salt-sensitive (SS/Jr) rat strain, designated as S, was from our
colony. The LEW/NCrlBR rat strain was originally obtained from Charles River
Laboratories (Wilmington, MA, USA) and is referred to as LEW. The congenic
substrains used in this study, namely, S.LEWx12x1, S.LEWx12x2, S.LEWx12x3,
S.LEWx12x4, and S.LEWx12x6, were derived from the congenic strain
S.LEWx12, previously developed by our group [15]. The congenic substrains
S.LEWx12x2x1 and S.LEWx12x2x3 were derived from S.LEWx12x2. All
congenic strains/substrains had the LEW chromosomal region of interest
introgressed onto the genetic background of the S rat strain. To obtain these
congenic substrains, the S.LEWx12 congenicwas crossed to the S strain to yield F1
rats that were heterozygous for the original introgressed chromosomal segment. F1
rats were intercrossed to obtain F2 rats that were genotyped for markers in the
congenic segment to look for recombinants. Rats with appropriate recombinant
chromosomes were crossed to S again to duplicate the recombinant chromosome.
The offspring were genotyped to select rats retaining the desired recombinant
region. Two rats with the same recombinant chromosomal segment were crossed
and the litters were genotyped to obtain rats that were homozygous throughout the
recombinant region of interest. The homozygous rats were crossed to fix the
recombinant chromosomal segment in a new congenic substrain.
Markers
The markers with D10Mco as the prefix were developed at the University of
Toledo Health Science Campus (formerly known as the Medical College of Ohio)
using rat genomic DNA sequence obtained from the Ensembl Web site (www.
ensembl.org). These can be accessed on ourWeb site (http://hsc.utoledo.edu/depts/
physiology/research/rat/marker.html). The D10Rat marker sequences were
obtained from the Whitehead Institute/MIT Center for Genome Research (www.
broad.mit.edu/rat/public), Rat Genomic Mapping Project. The D10Arb marker
sequences were obtained from the National Institute of Arthritis and Musculoske-
letal and Skin Diseases (www.nih.gov/niams/scientific/ratgbase/index.htm). The
D10Got marker sequences were obtained from the Wellcome Trust Center for
Human Genetics (www.well.ox.ac.uk/rat_mapping_resources). The D10Uia
marker sequences were obtained from the University of Iowa [46] and the primer
sequences are available at the Rat genome database (http://rgd.mcw.edu/).
Genotyping
DNAwas extracted from a tail biopsy using the QIAamp Tissue Kit (Qiagen,
Inc., Valencia, CA, USA). Polymerase chain reaction (PCR) genotyping with
microsatellite markers was done as described earlier [8].
Blood pressure measurement
We employed an experimental design in which the BP of a congenic strain was
compared only to its own separate group of control S rats that were bred, housed,
and studied concomitantly. Rats were weaned at 30 days of age to a low-salt (0.3%
NaCl) Harlan Teklad diet 7034 (Madison, WI, USA). Twenty male congenic
substrain rats were matched by age and weight with 20male S control rats and were
caged in 10 cages, each cage containing 2 congenics and 2 S rats. At 40–42 days of
age, the rats were fed a 2%NaClHarlan Teklad diet, TD94217, for 24 days. Systolic
blood pressurewasmeasured using the tail-cuff method on conscious restrained rats
warmed to 28°C. The operator did not know the identity of the rat during these
measurements. BPwasmeasured on each rat once a day for 4 consecutive days. The
BP value of each day was the average of three or four consistent readings. The final
BP value used was the averaged BP value of the 4 days. Rats were killed with CO2
and body and heart weights were measured. Statistical analysis was done using
programs in the SPSS software (SPSS, Chicago, IL, USA).
Corroboration of tail-cuff BP measurements by telemetry
For the S.LEWx12x2 congenic substrain, BP was also collected using a
telemetry system (Data Sciences International, St. Paul, MN, USA). Briefly, after
352 Y. Saad et al. / Genomics 89 (2007) 343–353the tail-cuff measurements were completed, eight S and eight congenic rats were
randomly selected from the whole group. At 70–73 days of age a transmitter was
surgically implanted into the left flank of each rat and the probe was inserted
through the femoral artery and advanced to the lower abdominal aorta.
The rats continued on the 2% NaCl diet for the duration of the experiment.
The animals were allowed to recover for 1 week before BP data was collected for
a period of 8 days.
Sequencing
mRNA from S and LEW kidney, liver, heart, lung, thyroid, pancreas, and
spleen was extracted using TRIzol reagent (Invitrogen), according to the
manufacturer’s recommendation. S and LEW full-length cDNA of the genes
within the QTL region was obtained by reverse transcription using the
SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen),
according to the provided protocol. Standard polymerase chain reaction, using
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) and gene-specific
primers, was used to amplify the cDNA. S and LEW gene amplicons were
cloned into the Topo-TA-Cloning System (Invitrogen), according to the
manufacturer’s recommendation. Plasmid DNAwas purified using the QIAprep
miniprep (Qiagen), according to the provided protocol. The full-length S and
LEW alleles for each gene within the QTL region were sequenced by MWG
(High Point, NC, USA), using vector-based and gene-specific primers. cDNA
variants were confirmed by sequencing PCR amplicons of their respective exons
found on genomic DNA. The three nonsynonymous variants were confirmed in
multiple S and LEW rats as well as genomic DNA obtained from MNS, MHS,
SHRSP, and WKY strains and the NGFRx12x2 congenic substrain. We also
sequenced PCR amplicons of genomic DNA exons for the few genes for which
we were not able to obtain cDNA. Intronic gene-specific primers, flanking each
exon, were used to PCR amplify and sequence all the exons for those genes.
Only the coding regions for all 18 genes were sequenced.
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